Please wait a minute...
Protein & Cell

ISSN 1674-800X

ISSN 1674-8018(Online)

CN 11-5886/Q

Postal Subscription Code 80-984

2018 Impact Factor: 7.575

Prot Cell    2011, Vol. 2 Issue (8) : 656-671    https://doi.org/10.1007/s13238-011-1082-6      PMID: 21904981
RESEARCH ARTICLE
Chain length-dependent cooperativity in fatty acid binding and oxidation by cytochrome P450BM3 (CYP102A1)
Benjamin Rowlatt, Jake A. Yorke, Anthony J. Strong, Christopher J. C. Whitehouse, Stephen G. Bell, Luet-Lok Wong()
Department of Chemistry, University of Oxford, Inorganic Chemistry Laboratory, South Parks Road, Oxford OX1 3QR, UK
 Download: PDF(663 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Fatty acid binding and oxidation kinetics for wild type P450BM3 (CYP102A1) from Bacillus megaterium have been found to display chain length-dependent homotropic behavior. Laurate and 13-methyl-myristate display Michaelis-Menten behavior while there are slight deviations with myristate at low ionic strengths. Palmitate shows Michaelis-Menten kinetics and hyperbolic binding behavior in 100 mmol/L phosphate, pH 7.4, but sigmoidal kinetics (with an apparent intercept) in low ionic strength buffers and at physiological phosphate concentrations. In low ionic strength buffers both the heme domain and the full-length enzyme show complex palmitate binding behavior that indicates a minimum of four fatty acid binding sites, with high cooperativity for the binding of the fourth palmitate molecule, and the full-length enzyme showing tighter palmitate binding than the heme domain. The first flavin-to-heme electron transfer is faster for laurate, myristate and palmitate in 100 mmol/L phosphate than in 50 mmol/L Tris (pH 7.4), yet each substrate induces similar high-spin heme content. For palmitate in low phosphate buffer concentrations, the rate constant of the first electron transfer is much larger than kcat. The results suggest that phosphate has a specific effect in promoting the first electron transfer step, and that P450BM3 could modulate Bacillus membrane morphology and fluidity via palmitate oxidation in response to the external phosphate concentration.

Keywords P450BM3      monooxygenase      fatty acid      cooperativity      allosteric effect      CYP102A1     
Corresponding Author(s): Wong Luet-Lok,Email:luet.wong@chem.ox.ac.uk   
Issue Date: 01 August 2011
 Cite this article:   
Benjamin Rowlatt,Jake A. Yorke,Anthony J. Strong, et al. Chain length-dependent cooperativity in fatty acid binding and oxidation by cytochrome P450BM3 (CYP102A1)[J]. Prot Cell, 2011, 2(8): 656-671.
 URL:  
https://academic.hep.com.cn/pac/EN/10.1007/s13238-011-1082-6
https://academic.hep.com.cn/pac/EN/Y2011/V2/I8/656
50 mmol/L TrisWith added Tris (mmol/L)With added phosphate (mmol/L)With added KCl (mmol/L)
100200300400100200300400100200300400
Laurate40455060654555606545506065
Myristate65707580806570758065707575
Palmitate95959595959595959595959595
Tab.1  Percentage of high spin heme content (estimated to within 5%) of fatty acid-bound full-length P450 at 30°C, pH 7.4, in different buffers and salt concentrations
Fig.1  Time courses at 30°C, pH 7.4 for Fe-CO complex formation monitored at 450 nm for P450.
(A) Laurate in 50 mmol/L Tris, which required a single exponential ( = 53.1s) to fit the data. (B) Laurate in 100 mmol/L phosphate, which required a double exponential to fit contributions from the fast phase ( = 108s) and a denatured phase ( = 30s), the fast phase accounting for 88% of the amplitude. (C) Myristate in 50 mmol/L Tris (single exponential fit: = 98s). (D) Myristate in 100 mmol/L phosphate (double exponential fit: = 226s, 56%; = 33s, 44%). (E) Palmitate in 50 mmol/L Tris (double exponential fit: = 218s, 52%; = 31s, 48%). (F) Palmitate in 100 mmol/L phosphate (double exponential fit: = 306s, 41%; = 37s, 59%).
Fig.1  Time courses at 30°C, pH 7.4 for Fe-CO complex formation monitored at 450 nm for P450.
(A) Laurate in 50 mmol/L Tris, which required a single exponential ( = 53.1s) to fit the data. (B) Laurate in 100 mmol/L phosphate, which required a double exponential to fit contributions from the fast phase ( = 108s) and a denatured phase ( = 30s), the fast phase accounting for 88% of the amplitude. (C) Myristate in 50 mmol/L Tris (single exponential fit: = 98s). (D) Myristate in 100 mmol/L phosphate (double exponential fit: = 226s, 56%; = 33s, 44%). (E) Palmitate in 50 mmol/L Tris (double exponential fit: = 218s, 52%; = 31s, 48%). (F) Palmitate in 100 mmol/L phosphate (double exponential fit: = 306s, 41%; = 37s, 59%).
kf (s-1) in phosphate (mmol/L)kf (s-1) in Tris (mmol/L)
102510020030050100250
Laurate107±21117±8118±1258±7.651±9.850±3.7
Myristate223±23102±7
Palmitate234±7305±19303±24288±23279±24227±15218±33217±39
Tab.2  Values of (s), the rate constant for the formation of the Fe-CO form of P450 complexed with laurate, myristate and palmitate in different concentrations of Tris and phosphate buffers (30°C, pH 7.4)
Fig.2  Kinetic titrations of P450 at 30°C, pH 7.4.
(A) With laurate in 50 mmol/L Tris and 100 mmol/L phosphate. (B) With myristate in 50 mmol/L Tris. (C) With palmitate in 50 mmol/L Tris. (D) With palmitate in 100 mmol/L phosphate. The enzyme concentration was 0.1 μmol/L. All data were fitted to hyperbolic functions except for (C) where a Hill equation with an intercept was used.
Fig.2  Kinetic titrations of P450 at 30°C, pH 7.4.
(A) With laurate in 50 mmol/L Tris and 100 mmol/L phosphate. (B) With myristate in 50 mmol/L Tris. (C) With palmitate in 50 mmol/L Tris. (D) With palmitate in 100 mmol/L phosphate. The enzyme concentration was 0.1 μmol/L. All data were fitted to hyperbolic functions except for (C) where a Hill equation with an intercept was used.
100 mmol/L phosphate50 mmol/L Tris
kcat (s-1)KM/H (μmol/L)nkcat (s-1)KM/H (μmol/L)n
Laurate82±2.0170±12173±2.5239±211
Myristate138±3.170±2.7194±3.479±5.01.2
Palmitate122±5.983±9.0187±1.452±1.04.8±0.3*
Tab.3  Apparent kinetic parameters for the oxidation of laurate, myristate and palmitate in 50 mmol/L Tris and 100 mmol/L phosphate (30°C, pH 7.4) with the enzyme concentration at 0.1 μmol/L
Fig.3  Kinetic titrations of P450.
P450 (0.1 μmol/L) with palmitate at pH 7.4, 30°C, showing the onset of sigmoidal behaviour at 50 mmol/L phosphate (A–C), and in 10 mmol/L phosphate (E) with added ammonium sulfate (D) and sodium carbonate (F) showing the effect of ionic strength. The data for low phosphate buffer concentrations, in panels (C–F), were fitted to a modified Hill equation with an intercept; black lines depict best fits where the intercept was allowed to vary, while fits using the background NADPH consumption rate of 0.5 s in the absence of substrate as the intercept are shown as red dashed lines.
Fig.3  Kinetic titrations of P450.
P450 (0.1 μmol/L) with palmitate at pH 7.4, 30°C, showing the onset of sigmoidal behaviour at 50 mmol/L phosphate (A–C), and in 10 mmol/L phosphate (E) with added ammonium sulfate (D) and sodium carbonate (F) showing the effect of ionic strength. The data for low phosphate buffer concentrations, in panels (C–F), were fitted to a modified Hill equation with an intercept; black lines depict best fits where the intercept was allowed to vary, while fits using the background NADPH consumption rate of 0.5 s in the absence of substrate as the intercept are shown as red dashed lines.
kcat (s-1)KM/H (μmol/L)nvo (s-1)
10 mmol/L32±1.031±1.34.011
25 mmol/L56±1.150±1.34.811
50 mmol/L98±6.665±7.21.4
75 mmol/L116±6.989±111
100 mmol/L122±5.983±9.01
10 mmol/L+ 15 mmol/L Na2CO3 + 15 mmol/L (NH4)2SO440±0.735±1.34.35
72±1.868±2.63.720
25 mmol/L+ 50 mmol/L Tris95±3.362±3.02.316
Tab.4  Apparent kinetic parameters for the oxidation of palmitate by P450 in different phosphate buffer concentrations and in mixtures with other compounds
Fig.4  Plots of peak-to-trough separations in the difference spectra for binding titrations for the heme domain of P450 at 30°C, pH 7.4.
(A) Laurate in 50 mmol/L Tris and 100 mmol/L phosphate; the enzyme concentration in both buffers was 0.5 μmol/L. (B) Myristate in 50 mmol/L Tris at an enzyme concentration of 5 μmol/L. The laurate binding data were fitted to a rectangular hyperbola. The data for myristate binding showed a slight kink in the 10-12 μmol/L concentration range but gave an acceptable fit to a hyperbolic function.
Fig.4  Plots of peak-to-trough separations in the difference spectra for binding titrations for the heme domain of P450 at 30°C, pH 7.4.
(A) Laurate in 50 mmol/L Tris and 100 mmol/L phosphate; the enzyme concentration in both buffers was 0.5 μmol/L. (B) Myristate in 50 mmol/L Tris at an enzyme concentration of 5 μmol/L. The laurate binding data were fitted to a rectangular hyperbola. The data for myristate binding showed a slight kink in the 10-12 μmol/L concentration range but gave an acceptable fit to a hyperbolic function.
Fig.5  Palmitate binding titrations with P450 at 30°C, pH 7.4 showing the plot of peak-to-trough separations ( - ), scaled for dilution.
(A) For the heme domain (1 μmol/L) in 100 mmol/L phosphate. (B) For the heme domain (5 μmol/L) in 50 mmol/L Tris. (C) For the full-length enzyme (2.5 μmol/L) in 50 mmol/L Tris. (D) For the heme domain (5 μmol/L) in 10 mmol/L phosphate. The data in (A) were fitted to a two-site binding model while the complex behaviour in (B–D) required a four-site binding model.
Fig.5  Palmitate binding titrations with P450 at 30°C, pH 7.4 showing the plot of peak-to-trough separations ( - ), scaled for dilution.
(A) For the heme domain (1 μmol/L) in 100 mmol/L phosphate. (B) For the heme domain (5 μmol/L) in 50 mmol/L Tris. (C) For the full-length enzyme (2.5 μmol/L) in 50 mmol/L Tris. (D) For the heme domain (5 μmol/L) in 10 mmol/L phosphate. The data in (A) were fitted to a two-site binding model while the complex behaviour in (B–D) required a four-site binding model.
Fig.6  Difference spectra for the binding titration of palmitic acid with the P450 heme domain in 50 mmol/L Tris, pH 7.4 at 30°C.
The protein concentration was 5 μmol/L. The difference spectra in the presence of various total concentrations of palmitic acid, added from stock solutions in DMSO, are shown. The total concentration of DMSO added was 2% (). Inset shows the plot of the peak-to-trough difference ( - ), scaled for dilution, against the total substrate concentration.
Fig.6  Difference spectra for the binding titration of palmitic acid with the P450 heme domain in 50 mmol/L Tris, pH 7.4 at 30°C.
The protein concentration was 5 μmol/L. The difference spectra in the presence of various total concentrations of palmitic acid, added from stock solutions in DMSO, are shown. The total concentration of DMSO added was 2% (). Inset shows the plot of the peak-to-trough difference ( - ), scaled for dilution, against the total substrate concentration.
Fig.7  Difference spectra for binding titrations at 30°C, pH 7.4 of palmitic acid with P450.
(A) The heme domain (5 μmol/L) in 10 mmol/L phosphate, and (B) the full-length enzyme (2.5 μmol/L) in 50 mmol/L Tris. Palmitic acid was added from stock solutions in DMSO and the total concentration of DMSO added was 2% ().
Fig.7  Difference spectra for binding titrations at 30°C, pH 7.4 of palmitic acid with P450.
(A) The heme domain (5 μmol/L) in 10 mmol/L phosphate, and (B) the full-length enzyme (2.5 μmol/L) in 50 mmol/L Tris. Palmitic acid was added from stock solutions in DMSO and the total concentration of DMSO added was 2% ().
K1 (μmol/L) ΔA1K2 (μmol/L) ΔA2K3 (μmol/L) ΔA3K4 (μmol/L) ΔA4
Heme domain P450BM3
10 mmol/L phosphate6.15±1.04.70±0.07320±251.61±0.22
0.63±0.070.09±0.020.10±0.010.41±0.02
50 mmol/L Tris6.50±0.5010.0±1.51380±301.80±0.25
0.92±0.080.10±0.010.05±0.010.56±0.01
Full-length P450BM3
50 mmol/L Tris1.20±0.0810.5±0.15128±102.0±0.17
0.27±0.020.14±0.020.10±0.010.25±0.01
Tab.5  Palmitate binding data for P450 in Tris and phosphate buffers
1 Baas, B.J., Denisov, I.G., and Sligar, S.G. (2004). Homotropic cooperativity of monomeric cytochrome P450 3A4 in a nanoscale native bilayer environment. Arch Biochem Biophys 430, 218–228 .
pmid:15369821
2 Bell, S.G., Dale, A., Rees, N.H., and Wong, L.L. (2010a). A cytochrome P450 class I electron transfer system from Novosphingobium aromaticivorans. Appl Microbiol Biotechnol 86, 163–175 .
pmid:19779713
3 Bell, S.G., Hoskins, N., Whitehouse, C.J.C., and Wong, L.-L. (2007). Design and Engineering of Cytochrome P450 Systems. Metal Ions Life Sci 3, 437–476 .
4 Bell, S.G., Tan, A.B., Johnson, E.O., and Wong, L.L. (2010b). Selective oxidative demethylation of veratric acid to vanillic acid by CYP199A4 from Rhodopseudomonas palustris HaA2. Mol Biosyst 6, 206–214 .
pmid:20024082
5 Bell, S.G., and Wong, L.L. (2007). P450 enzymes from the bacterium Novosphingobium aromaticivorans. Biochem Biophys Res Commun 360, 666–672 .
pmid:17618912
6 Bell, S.G., Xu, F., Johnson, E.O., Forward, I.M., Bartlam, M., Rao, Z., and Wong, L.L. (2010c). Protein recognition in ferredoxin-P450 electron transfer in the class I CYP199A2 system from Rhodopseudomonas palustris. J Biol Inorg Chem 15, 315–328 .
pmid:19904564
7 Brewer, C.B., and Peterson, J.A. (1988). Single turnover kinetics of the reaction between oxycytochrome P-450cam and reduced putidaredoxin. J Biol Chem 263, 791–798 .
pmid:2826462
8 Budde, M., Maurer, S.C., Schmid, R.D., and Urlacher, V.B. (2004). Cloning, expression and characterisation of CYP102A2, a self-sufficient P450 monooxygenase from Bacillus subtilis. Appl Microbiol Biotechnol 66, 180–186 .
pmid:15375636
9 Carmichael, A.B., and Wong, L.L. (2001). Protein engineering of Bacillus megaterium CYP102. The oxidation of polycyclic aromatic hydrocarbons. Eur J Biochem 268, 3117–3125 .
pmid:11358532
10 Chowdhary, P.K., Alemseghed, M., and Haines, D.C. (2007). Cloning, expression and characterization of a fast self-sufficient P450: CYP102A5 from Bacillus cereus. Arch Biochem Biophys 468, 32–43 .
pmid:17945181
11 Cryle, M.J., Espinoza, R.D., Smith, S.J., Matovic, N.J., and De Voss, J.J. (2006). Are branched chain fatty acids the natural substrates for P450(BM3)? Chem Commun 2353–2355 .
pmid:16733577
12 Davydov, D.R., Botchkareva, A.E., Kumar, S., He, Y.Q., and Halpert, J.R. (2004). An electrostatically driven conformational transition is involved in the mechanisms of substrate binding and cooperativity in cytochrome P450eryF. Biochemistry 43, 6475–6485 .
pmid:15157081
13 Davydov, D.R., and Halpert, J.R. (2008). Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both? Expert Opin Drug Metab Toxicol 4, 1523–1535 .
pmid:19040328
14 Denisov, I.G., Baas, B.J., Grinkova, Y.V., and Sligar, S.G. (2007). Cooperativity in cytochrome P450 3A4: linkages in substrate binding, spin state, uncoupling, and product formation. J Biol Chem 282, 7066–7076 .
pmid:17213193
15 Denisov, I.G., Frank, D.J., and Sligar, S.G. (2009). Cooperative properties of cytochromes P450. Pharmacol Ther 124, 151–167 .
pmid:19555717
16 Dietrich, M., Eiben, S., Asta, C., Do, T.A., Pleiss, J., and Urlacher, V.B. (2008). Cloning, expression and characterisation of CYP102A7, a self-sufficient P450 monooxygenase from Bacillus licheniformis. Appl Microbiol Biotechnol 79, 931–940 .
pmid:18483737
17 Girvan, H.M., Dunford, A.J., Neeli, R., Ekanem, I.S., Waltham, T.N., Joyce, M.G., Leys, D., Curtis, R.A., Williams, P., Fisher, K., (2011). Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer. Arch Biochem Biophys 507, 75–85 .
pmid:20868649
18 Guengerich, F.P. (2001). Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14, 611–650 .
pmid:11409933
19 Gustafsson, M.C., Roitel, O., Marshall, K.R., Noble, M.A., Chapman, S.K., Pessegueiro, A., Fulco, A.J., Cheesman, M.R., von Wachenfeldt, C., and Munro, A.W. (2004). Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium. Biochemistry 43, 5474–5487 .
pmid:15122913
20 Haines, D.C., Chen, B., Tomchick, D.R., Bondlela, M., Hegde, A., Machius, M., and Peterson, J.A. (2008). Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel. Biochemistry 47, 3662–3670 .
pmid:18298086
21 Haines, D.C., Sevrioukova, I.F., and Peterson, J.A. (2000). The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution. Biochemistry 39, 9419–9429 .
pmid:10924137
22 Haines, D.C., Tomchick, D.R., Machius, M., and Peterson, J.A. (2001). Pivotal role of water in the mechanism of P450BM-3. Biochemistry 40, 13456–13465 .
pmid:11695892
23 Hasemann, C.A., Kurumbail, R.G., Boddupalli, S.S., Peterson, J.A., and Deisenhofer, J. (1995). Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure 3, 41–62 .
pmid:7743131
24 Hegde, A., Haines, D.C., Bondlela, M., Chen, B., Schaffer, N., Tomchick, D.R., Machius, M., Nguyen, H., Chowdhary, P.K., Stewart, L., (2007). Interactions of substrates at the surface of P450s can greatly enhance substrate potency. Biochemistry 46, 14010–14017 .
pmid:18004886
25 Huang, W.C., Westlake, A.C., Maréchal, J.D., Joyce, M.G., Moody, P.C., and Roberts, G.C. (2007). Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency. J Mol Biol 373, 633–651 .
pmid:17868686
26 Ingelman-Sundberg, M., and Johansson, I. (1980). Catalytic properties of purified forms of rabbit liver microsomal cytochrome P-450 in reconstituted phospholipid vesicles. Biochemistry 19, 4004–4011 .
pmid:6773560
27 Jovanovic, T., Farid, R., Friesner, R.A., and McDermott, A.E. (2005). Thermal equilibrium of high- and low-spin forms of cytochrome P450 BM-3: repositioning of the substrate? J Am Chem Soc 127, 13548–13552 .
pmid:16190718
28 Joyce, M.G., Girvan, H.M., Munro, A.W., and Leys, D. (2004). A single mutation in cytochrome P450 BM3 induces the conformational rearrangement seen upon substrate binding in the wild-type enzyme. J Biol Chem 279, 23287–23293 .
pmid:15020590
29 Kitazume, T., Haines, D.C., Estabrook, R.W., Chen, B., and Peterson, J.A. (2007). Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3. Biochemistry 46, 11892–11901 .
pmid:17902705
30 Lentz, O., Urlacher, V., and Schmid, R.D. (2004). Substrate specificity of native and mutated cytochrome P450 (CYP102A3) from Bacillus subtilis. J Biotechnol 108, 41–49 .
pmid:14741768
31 Li, H., and Poulos, T.L. (1997). The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nat Struct Biol 4, 140–146 .
pmid:9033595
32 Li, Q.S., Ogawa, J., Schmid, R.D., and Shimizu, S. (2005). Indole hydroxylation by bacterial cytochrome P450BM-3 and modulation of activity by cumene hydroperoxide. Biosci Biotechnol Biochem 69, 293–300 .
pmid:15725653
33 Malik, W.U., and Jain, A.K. (1967). Electrometric determination of critical micelle concentrations of soap solutions. J Electroanal Chem 14, 37–41 .
34 Maurer, S.C., Kuhnel, K., Kaysser, L.A., Eiben, S., Schmid, R.D., and Urlacher, V.B. (2005). Catalytic hydroxylation in biphasic systems using CYP102A1 mutants. Adv Synth Catal 347, 1090–1098 .
35 Maves, S.A., Yeom, H., McLean, M.A., and Sligar, S.G. (1997). Decreased substrate affinity upon alteration of the substrate-docking region in cytochrome P450BM-3. FEBS Lett 414, 213–218 .
pmid:9315688
36 Mizushima, S., Ishida, M., and Kitahara, K. (1966). Chemical composition of the protoplast membrane of Bacillus megaterium. J Biochem 59, 374–381 .
pmid:4959361
37 Modi, S., Primrose, W.U., Lian, L.Y., and Roberts, G.C. (1995). Effect of replacement of ferriprotoporphyrin IX in the haem domain of cytochrome P-450 BM-3 on substrate binding and catalytic activity. Biochem J 310, 939–943 .
pmid:7575430
38 Munro, A.W., Daff, S., Coggins, J.R., Lindsay, J.G., and Chapman, S.K. (1996). Probing electron transfer in flavocytochrome P-450 BM3 and its component domains. Eur J Biochem 239, 403–409 .
pmid:8706747
39 Narhi, L.O., and Fulco, A.J. (1986). Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. J Biol Chem 261, 7160–7169 .
pmid:3086309
40 Narhi, L.O., and Fulco, A.J. (1987). Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium. J Biol Chem 262, 6683–6690 .
pmid:3106360
41 Neeli, R., Girvan, H.M., Lawrence, A., Warren, M.J., Leys, D., Scrutton, N.S., and Munro, A.W. (2005). The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase. FEBS Lett 579, 5582–5588 .
pmid:16214136
42 Noble, M.A., Miles, C.S., Chapman, S.K., Lysek, D.A., MacKay, A.C., Reid, G.A., Hanzlik, R.P., and Munro, A.W. (1999). Roles of key active-site residues in flavocytochrome P450 BM3. Biochem J 339, 371–379 .
pmid:10191269
43 Ost, T.W., Clark, J., Mowat, C.G., Miles, C.S., Walkinshaw, M.D., Reid, G.A., Chapman, S.K., and Daff, S. (2003). Oxygen activation and electron transfer in flavocytochrome P450 BM3. J Am Chem Soc 125, 15010–15020 .
pmid:14653735
44 Roberts, A.G., Campbell, A.P., and Atkins, W.M. (2005). The thermodynamic landscape of testosterone binding to cytochrome P450 3A4: ligand binding and spin state equilibria. Biochemistry 44, 1353–1366 .
pmid:15667229
45 Rock, D.A., Perkins, B.N.S., Wahlstrom, J., and Jones, J.P. (2003). A method for determining two substrates binding in the same active site of cytochrome P450BM3: an explanation of high energy omega product formation. Arch Biochem Biophys 416, 9–16 .
pmid:12859976
46 Urlacher, V.B., and Eiben, S. (2006). Cytochrome P450 monooxygenases: perspectives for synthetic application. Trends Biotechnol 24, 324–330 .
pmid:16759725
47 van Vugt-Lussenburg, B.M., Damsten, M.C., Maasdijk, D.M., Vermeulen, N.P., and Commandeur, J.N. (2006). Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3. Biochem Biophys Res Commun 346, 810–818 .
pmid:16777067
48 Whitehouse, C.J., Bell, S.G., Tufton, H.G., Kenny, R.J., Ogilvie, L.C., and Wong, L.L. (2008). Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options. Chem Commun 966–968 .
pmid:18283351
49 Whitehouse, C.J., Bell, S.G., Yang, W., Yorke, J.A., Blanford, C.F., Strong, A.J., Morse, E.J., Bartlam, M., Rao, Z., and Wong, L.L. (2009). A highly active single-mutation variant of P450BM3 (CYP102A1). Chembiochem 10, 1654–1656 .
pmid:19492389
50 Whitehouse, C.J., Yang, W., Yorke, J.A., Rowlatt, B.C., Strong, A.J., Blanford, C.F., Bell, S.G., Bartlam, M., Wong, L.L., and Rao, Z. (2010). Structural basis for the properties of two single-site proline mutants of CYP102A1 (P450BM3). Chembiochem 11, 2549–2556 .
pmid:21110374
51 Whitehouse, C.J.C., Yang, W., Yorke, J.A., Tufton, H.G., Ogilvie, L.C.I., Bell, S.G., Zhou, W., Bartlam, M., Rao, Z., and Wong, L.L. (2011). Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450BM3) variant. Dalton Trans May20. [Epub ahead of print]
52 Yang, W., Bell, S.G., Wang, H., Zhou, W., Hoskins, N., Dale, A., Bartlam, M., Wong, L.L., and Rao, Z. (2010). Molecular characterization of a class I P450 electron transfer system from Novosphingobium aromaticivorans DSM12444. J Biol Chem 285, 27372–27384 .
pmid:20576606
53 Yeom, H.Y., and Sligar, S.G. (1997). Oxygen activation by cytochrome P450BM-3: effects of mutating an active site acidic residue. Arch Biochem Biophys 337, 209–216 .
pmid:9016815
[1] Yaoting Deng,Yurika Matsui,Wenfei Pan,Qiu Li,Zhi-Chun Lai. Yap1 plays a protective role in suppressing free fatty acid-induced apoptosis and promoting beta-cell survival[J]. Protein Cell, 2016, 7(5): 362-372.
[2] Yongchang Zhang,Rongsui Gao,Huiyan Ye,Qingjing Wang,Youjun Feng. A new glimpse of FadR-DNA crosstalk revealed by deep dissection of the E. coli FadR regulatory protein[J]. Protein Cell, 2014, 5(12): 928-939.
[3] Xiangyang Liu, Xinyi Tao, Aihua Zou, Shizhong Yang, Bozhong Mu, Lixin Zhang, . Effect of the microbial lipopeptide on tumor cell lines: apoptosis induced by disturbing the fatty acid composition of cell membrane[J]. Protein Cell, 2010, 1(6): 584-594.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed